Furthermore, inhibitors of Sirt 1/2, cambinol and inhibitor VII, have been shown to decrease aromatase mRNA and protein levels in ER+ (MCF7) and ER- (MB-231) BC cell models [146]. The gene discussed is CYP19A1; the disease is breast cancer.